Comparative analysis of routine biochemistry data and neurohormonal markers in patients with different forms of pulmonary hypertension

Y. Andreeva, O. O. Matvienko, T. V. Martynyuk, N. M. Danilov, T. V. Kuznecova, V. P. Masenko, I. Y. Chazova (Moscow, Russian Federation)

Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Session: Management of sarcoidosis and lung manifestations of systemic diseases
Session type: Thematic Poster Session
Number: 606

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Andreeva, O. O. Matvienko, T. V. Martynyuk, N. M. Danilov, T. V. Kuznecova, V. P. Masenko, I. Y. Chazova (Moscow, Russian Federation). Comparative analysis of routine biochemistry data and neurohormonal markers in patients with different forms of pulmonary hypertension. Eur Respir J 2010; 36: Suppl. 54, 606

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparative analysis of the plasma metabolomics in rodent models of pulmonary hypertension and patients with IPAH shows different metabolic signatures
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019

Genetic findings in patients with different forms of pulmonary hypertension
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020




Comparative evaluation of diagnosis methods in the patients with pulmonary sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 539s
Year: 2006

Proteomic profiling identifies an exercise signature in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


Evaluation of the relationship between laboratory parameters and pulmonary function tests in COVID-19 patients
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021

Impact of the state of endothelium on clinical and functional parameters in COPD patients with arterial hypertension.
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017




Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J 2014; 44: 951-962
Year: 2014



Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015

Combining physiology and imaging in the diagnosis of pulmonary hypertension
Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines
Year: 2019


Comparative assessment of hemodynamic parameters in patients with COPD and CHD treated with different groups of bronchodilators.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018

A new molecular genetic diagnostic approach for pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Hemodynamic phenotypes in systemic sclerosis patients screened for pulmonary hypertension – impact of the new PH-definition
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019


Coagulation disorders in pulmonary hypertension. Correlations with haemodynamic data
Source: Eur Respir J 2003; 22: Suppl. 45, 437s
Year: 2003

The clinical role of routine non-invasive parameters in the diagnostic work-up of patients with risk for pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Year: 2012

Early diagnostic evaluation of pulmonary hypertension in severe COPD patients (preliminary results)
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006

Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
Source: Eur Respir J 2016; 47: 388-389
Year: 2016


Use of discriminant analysis to assess pulmonary functional worsening in patients with sarcoidosis by means of a panel of inflammatory markers
Source: Annual Congress 2011 - Biomarkers in sarcoidosis
Year: 2011


Non-invasive hemodynamic assessment in patients with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


Comparison of sputum characteristics with clinical, laboratorial and functional variables in patients with stable COPD
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

Comparative population-genetic analysis of pulmonary tuberculosis patients and lung cancer patients
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008